RxDoctor Payments Data
★ My doctorsLook up a doctor →

Pei-Hsiu Huang, MD

Interventional Cardiology · Sacramento, CANPI 1992901573

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (55.0%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Edwards Lifesciences accounts for 74.9% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2020 at $27,226 and has fallen 58.0% since, to $11,437 in 2025.

$113,632in general payments, 2019–2025

Across 399 payments — averaging $284.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$85K
  • Medtronic$18K
  • Abbott$8K
  • Siemens Medical Solutions USA, Inc.$883
  • Abiomed$637
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$563
  • plus $972 from 11 others
$351,696in research payments, 2019–2025

Across 106 payments — averaging $3317.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$207K
  • Edwards Lifesciences$123K
  • Medtronic$22K

What the payments were for

  • Consulting fees$62,53855%
  • Speaking & faculty fees$3,0003%
  • Travel & lodging$28,24925%
  • Food & beverage$19,84617%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Edwards Lifesciences203$85,090
Medtronic(2 entities)94$17,936
Abbott63$7,552
Siemens Medical Solutions USA, Inc.6$883
Abiomed6$637
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)6$563
Inari Medical, Inc.3$260
Boston Scientific5$213
Recor Medical Inc2$147
Pfizer1$89
W. L. Gore & Associates, Inc.1$82
Philips North America LLC2$54
Cardiva Medical, Inc.2$48
Stryker1$25
Acutus Medical, Inc.2$20
B. Braun Interventional Systems Inc.1$20
Bard Peripheral Vascular, Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$113,632 in reported general payments places this provider in the 85th percentile of 585 interventional cardiology providers in California.

See all interventional cardiology providers in California →

Medicare billing

Part B allowed, 2024
$252,902
Medicare patients
327
Services billed
948

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate22$247
Atorvastatin Calcium21$175
Prednisone11$12

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Sacramento

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →